...
首页> 外文期刊>Investigative ophthalmology & visual science >Detection of Mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 Families With Early-Onset High Myopia by Exome Sequencing
【24h】

Detection of Mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 Families With Early-Onset High Myopia by Exome Sequencing

机译:外显子组测序检测298例早发性高度近视家庭LRPAP1,CTSH,LEPREL1,ZNF644,SLC39A5和SCO2的突变

获取原文
           

摘要

Purpose.: To evaluate variants in the LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 genes in 298 unrelated patients with early-onset high myopia (eoHM). Methods.: Genomic DNA from 298 patients with eoHM was analyzed by whole exome sequencing. Variants in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 genes were selected and analyzed with bioinformatics. Potential candidate variants were confirmed by Sanger sequencing and then validated in available family members and 192 healthy controls. Results.: A total of nine variants predicted to affect the functional residues were detected. The LRPAP1 gene showed a homozygous frameshift mutation (c.199delC, p.Q67Sfs*8) in a consanguineous family. The ZNF644 gene showed five heterozygous missense mutations (c.1106AT, p.K369M; c.1648GA, p.A550T; c.2014AG, p.S672G; c.2048GC, p.R683T, and c.2551GC, p.D851H) in five families, but the c.1106AT, (p.K369M) and c.1648GA, (p.A550T) in ZNF644 did not co-segregated with high myopia in the families and should be excluded as causative mutations. The SLC39A5 gene showed a heterozygous missense variant (c.1238GC, p.G413A) in a sporadic individual. The SCO2 gene showed two heterozygous missense variants (c.334CT, p.R112W and c.358CT, p.R120W) in two families. None of the variants was detected in 192 healthy controls and all were predicted to be damaging by both Polyphen-2 and SIFT, except for the previously reported p.S672G mutation in ZNF644, which was predicted to be damaging by SIFT but benign by Polyphen-2. No homozygous or compound heterozygous variants were found in CTSH and LEPREL1. Conclusions.: Our results provide additional evidence to support the idea that mutation in LRPAP1 is associated with high myopia. Further studies are expected to evaluate the pathogenicity of the variants in CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2.
机译:目的:评价298例不相关的早期发作的高度近视(eoHM)患者的LRPAP1,CTSH,LEPREL1,ZNF644,SLC39A5和SCO2基因的变异。方法:通过全外显子组测序分析了298例eoHM患者的基因组DNA。选择LRPAP1,CTSH,LEPREL1,ZNF644,SLC39A5和SCO2基因的变体,并用生物信息学进行分析。通过Sanger测序确认潜在的候选变体,然后在可用的家庭成员和192个健康对照中进行验证。结果:总共检测到九种预计会影响功能性残基的变体。 LRPAP1基因在近亲家庭中表现出纯合的移码突变(c.199delC,p.Q67Sfs * 8)。 ZNF644基因显示五个杂合错义突变(c.1106A> T,p.K369M; c.1648G> A,p.A550T; c.2014A> G,p.S672G; c.2048G> C,p.R683T和在5个家庭中,c.2551G> C,p.D851H),但ZNF644中的c.1106A> T(p.K369M)和c.1648G> A(p.A550T)在高度近视中并没有共同隔离家庭,应排除在因果突变之外。 SLC39A5基因在散发性个体中显示出杂合的错义变体(c.1238G> C,p.G413A)。 SCO2基因在两个家族中显示了两个杂合的错义变体(c.334C> T,p.R112W和c.358C> T,p.R120W)。在192个健康对照中均未检测到任何变异,除了先前报道的ZNF644中p.S672G突变(被SIFT损害而被Polyphen-损害)外,Polyphen-2和SIFT均被预测为损害。 2。在CTSH和LEPREL1中未发现纯合子或复合杂合子变体。结论:我们的结果提供了更多的证据来支持LRPAP1突变与高度近视有关的观点。预计将进行进一步的研究以评估CTSH,LEPREL1,ZNF644,SLC39A5和SCO2中变体的致病性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号